$SRIVARU Holding (SVMH.US)$
SVMH (SRIVARU Holding) shows high speculative potential, with a current oversold level indicating a possible short-term rebound. At $0.028, the stock is heavily discounted, with strong support at $0.026. If it holds, there’s significant upside, aiming for a recovery towards the resistance at $0.174—a potential gain of over 500%.
SVMH (SRIVARU Holding) shows high speculative potential, with a current oversold level indicating a possible short-term rebound. At $0.028, the stock is heavily discounted, with strong support at $0.026. If it holds, there’s significant upside, aiming for a recovery towards the resistance at $0.174—a potential gain of over 500%.
3
4
$Lyra Therapeutics (LYRA.US)$
The recent developments reported in Lyra Therapeutics’ latest 8-K filing present a mixed picture for investors:
Positive Aspects:
1. Cost Reduction: The workforce reduction is aimed at cutting operating expenses, which could improve the company’s financial health and increase shareholder value in the long run. This move shows the company’s proactive approach to managing costs and resources efficiently.
2. Retention of Key Executives: The approv...
The recent developments reported in Lyra Therapeutics’ latest 8-K filing present a mixed picture for investors:
Positive Aspects:
1. Cost Reduction: The workforce reduction is aimed at cutting operating expenses, which could improve the company’s financial health and increase shareholder value in the long run. This move shows the company’s proactive approach to managing costs and resources efficiently.
2. Retention of Key Executives: The approv...
5
1
$Citius Pharmaceuticals (CTXR.US)$
Hey Moomoo community,
I wanted to provide an updated analysis on $Citius Pharmaceuticals (CTXR.US)$ to help us all stay informed and navigate our investment decisions.
Recent Developments:
1. Financial Performance:
• Q1 2024 Results: Citius reported a better-than-expected performance in Q1 2024, with significant developments including the resubmission of the Biologics License Application (BLA) fo...
Hey Moomoo community,
I wanted to provide an updated analysis on $Citius Pharmaceuticals (CTXR.US)$ to help us all stay informed and navigate our investment decisions.
Recent Developments:
1. Financial Performance:
• Q1 2024 Results: Citius reported a better-than-expected performance in Q1 2024, with significant developments including the resubmission of the Biologics License Application (BLA) fo...
8
$Sunshine Biopharma (SBFM.US)$
Hey Moomoo community,
I wanted to share some insights and updates regarding Sunshine Biopharma (SBFM) to help us navigate the current challenges many of us are facing.
Recent Financial Performance:
• Positive Q1 2024 Results: SBFM reported better-than-expected earnings per share (EPS) of -$2.00, significantly improving from the expected -$8.00. The company also posted revenues of $7.54 million, exceeding the forecasted...
Hey Moomoo community,
I wanted to share some insights and updates regarding Sunshine Biopharma (SBFM) to help us navigate the current challenges many of us are facing.
Recent Financial Performance:
• Positive Q1 2024 Results: SBFM reported better-than-expected earnings per share (EPS) of -$2.00, significantly improving from the expected -$8.00. The company also posted revenues of $7.54 million, exceeding the forecasted...
9
3
1
$Citius Pharmaceuticals (CTXR.US)$
Bullish Scenario: If the price sustains above $0.70 and breaks through $0.85, it could retest the $1.00 resistance. A move above $1.076 could trigger further buying, potentially driving the price towards $1.20.
Bullish Scenario: If the price sustains above $0.70 and breaks through $0.85, it could retest the $1.00 resistance. A move above $1.076 could trigger further buying, potentially driving the price towards $1.20.
4
3
1
2
$Lytus Technologies Holdings (LYT.US)$
Based on the recent analysis of Lytus Technologies Holdings (LYT), here are three key points that might indicate potential profitability for the stock:
1. Expansion into High-Growth Markets: Lytus Technologies has recently entered the $326 billion data center market with the launch of Lytus Cloud Infrastructure Services. This move positions the company in a rapidly growing industry, potentially boosting revenue and market presence.
...
Based on the recent analysis of Lytus Technologies Holdings (LYT), here are three key points that might indicate potential profitability for the stock:
1. Expansion into High-Growth Markets: Lytus Technologies has recently entered the $326 billion data center market with the launch of Lytus Cloud Infrastructure Services. This move positions the company in a rapidly growing industry, potentially boosting revenue and market presence.
...
5
$Lyra Therapeutics (LYRA.US)$
Based on the charts and market data:
• The significant increase in short volume and short interest indicates a potential short squeeze.
• The support level is at $3.060, and the resistance is at $7.040.
• The current price action shows strong upward momentum.
Note: This analysis suggests potential for a short squeeze, but always consider the risks and do your own research before making any investment decisions. This i...
Based on the charts and market data:
• The significant increase in short volume and short interest indicates a potential short squeeze.
• The support level is at $3.060, and the resistance is at $7.040.
• The current price action shows strong upward momentum.
Note: This analysis suggests potential for a short squeeze, but always consider the risks and do your own research before making any investment decisions. This i...
6
1
$WiSA Technologies (WISA.US)$
Key Points to Watch
1. Earnings Report: WISA Technologies is expected to release its earnings report on May 21, 2024. This event could be a significant catalyst for the stock price, depending on the results.
2. Market Sentiment: Given the high short interest and increased short volume, positive news or better-than-expected earnings could trigger a short squeeze, propelling the stock price upward.
Conclusion
WISA Technologi...
Key Points to Watch
1. Earnings Report: WISA Technologies is expected to release its earnings report on May 21, 2024. This event could be a significant catalyst for the stock price, depending on the results.
2. Market Sentiment: Given the high short interest and increased short volume, positive news or better-than-expected earnings could trigger a short squeeze, propelling the stock price upward.
Conclusion
WISA Technologi...
8
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iMjYiIGhlaWdodD0iMjYiIHZpZXdCb3g9IjAgMCAyNiAyNiIgZmlsbD0ibm9uZSIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIj4KPHBhdGggZmlsbC1ydWxlPSJldmVub2RkIiBjbGlwLXJ1bGU9ImV2ZW5vZGQiIGQ9Ik0xMi45OTk5IDAuMzI1NDM5QzYuMDQxMTEgMC4zMjU0MzkgMC4zOTk5MDIgNS45NjY2NSAwLjM5OTkwMiAxMi45MjU0QzAuMzk5OTAyIDE5Ljg4NDIgNi4wNDExMSAyNS41MjU0IDEyLjk5OTkgMjUuNTI1NFYyMi43MjU0QzcuNTg3NTEgMjIuNzI1NCAzLjE5OTkgMTguMzM3OCAzLjE5OTkgMTIuOTI1NEMzLjE5OTkgNy41MTMwNSA3LjU4NzUxIDMuMTI1NDQgMTIuOTk5OSAzLjEyNTQ0VjAuMzI1NDM5WiIgZmlsbD0idXJsKCNwYWludDBfbGluZWFyXzIyMDBfNDg2NikiLz4KPHBhdGggZmlsbC1ydWxlPSJldmVub2RkIiBjbGlwLXJ1bGU9ImV2ZW5vZGQiIGQ9Ik0xMyAyNS41MjU0QzE5Ljk1ODggMjUuNTI1NCAyNS42IDE5Ljg4NDIgMjUuNiAxMi45MjU0QzI1LjYgNS45NjY2NSAxOS45NTg4IDAuMzI1NDQgMTMgMC4zMjU0MzlWMy4xMjU0NEMxOC40MTI0IDMuMTI1NDQgMjIuOCA3LjUxMzA1IDIyLjggMTIuOTI1NEMyMi44IDE4LjMzNzggMTguNDEyNCAyMi43MjU0IDEzIDIyLjcyNTRWMjUuNTI1NFoiIGZpbGw9InVybCgjcGFpbnQxX2xpbmVhcl8yMjAwXzQ4NjYpIi8+CjxjaXJjbGUgY3g9IjEzLjAwMDEiIGN5PSIyNC4xMjUzIiByPSIxLjQiIGZpbGw9InVybCgjcGFpbnQyX2xpbmVhcl8yMjAwXzQ4NjYpIi8+CjxkZWZzPgo8bGluZWFyR3JhZGllbnQgaWQ9InBhaW50MF9saW5lYXJfMjIwMF80ODY2IiB4MT0iNy4zOTk5IiB5MT0iMjUuNTI1NCIgeDI9IjcuMzk5OSIgeTI9IjIuNDI1NDQiIGdyYWRpZW50VW5pdHM9InVzZXJTcGFjZU9uVXNlIj4KPHN0b3Agc3RvcC1jb2xvcj0iIzdBN0E3QSIgc3RvcC1vcGFjaXR5PSIwIi8+CjxzdG9wIG9mZnNldD0iMSIgc3RvcC1jb2xvcj0iIzdBN0E3QSIgc3RvcC1vcGFjaXR5PSIwLjUiLz4KPC9saW5lYXJHcmFkaWVudD4KPGxpbmVhckdyYWRpZW50IGlkPSJwYWludDFfbGluZWFyXzIyMDBfNDg2NiIgeDE9IjIwIiB5MT0iMjUuNTI1NCIgeDI9IjIwIiB5Mj0iMi40MjU0NCIgZ3JhZGllbnRVbml0cz0idXNlclNwYWNlT25Vc2UiPgo8c3RvcCBzdG9wLWNvbG9yPSIjN0E3QTdBIi8+CjxzdG9wIG9mZnNldD0iMSIgc3RvcC1jb2xvcj0iIzdBN0E3QSIgc3RvcC1vcGFjaXR5PSIwLjUiLz4KPC9saW5lYXJHcmFkaWVudD4KPGxpbmVhckdyYWRpZW50IGlkPSJwYWludDJfbGluZWFyXzIyMDBfNDg2NiIgeDE9IjEzLjAwMDEiIHkxPSIyNC4xMjUzIiB4Mj0iMTQuNDAwMSIgeTI9IjI0LjEyNTMiIGdyYWRpZW50VW5pdHM9InVzZXJTcGFjZU9uVXNlIj4KPHN0b3Agc3RvcC1jb2xvcj0iIzdBN0E3QSIvPgo8c3RvcCBvZmZzZXQ9IjEiIHN0b3AtY29sb3I9IiM3QTdBN0EiIHN0b3Atb3BhY2l0eT0iMCIvPgo8L2xpbmVhckdyYWRpZW50Pgo8L2RlZnM+Cjwvc3ZnPgo=)
Kay Kay 66 OP TheDylz : If SVMH is indeed conducting an offering at $0.07, this means they are issuing new shares at a price higher than the current market price ($0.028). Offerings can dilute the value of existing shares, as more shares are added to the market, potentially lowering the stock price further. However, since the offering is above the current price, it can also set a floor or indicate that the company or investors believe in higher intrinsic value.